"While a record Rabi crop will help in moderating cereal prices,...
Category:
Eco/Invest/Demography
Latest
FIU notifies fresh money laundering, terror financing reporting alerts for insurance and capital market players
A working group, that included insurance regulator IRDAI, went into...
Chinese automakers redefine the car as a living space at Beijing Auto Show
Tang Daosheng, a senior executive from Chinese tech giant Tencent,...
Govt releases backend code of Aarogya Setu to enhance transparency
“Releasing backend code will help people in understanding the complete functioning of the app. This will clear any doubt that they have regarding privacy and security of their data,” a MeitY official explained.
Pfizer seeking emergency use of its Covid-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
EU could give conditional nod to Moderna vaccine as early as December
The EU could pay more than $10 billion to buy hundreds of millions of doses of the vaccine jointly developed by Pfizer Inc. and BioNTech as well as that of CureVac NV, Reuters said Friday, citing an EU official it didn’t name. The price it agreed for the Pfizer-BioNTech shot is 15.50 euros ($18.34) per dose, less than what the U.S. is paying, the newswire said.
Wealthy countries block COVID-19 drugs rights waiver at WTO – sources
Supporters of the waiver say existing intellectual property (IP) rules create barriers on access to affordable medicines and vaccines and they want restrictions to be eased, as they were during the AIDS epidemic.
Johnson & Johnson ordered to pay $120 million damages in New York baby powder case
Johnson & Johnson said it will appeal the verdict, citing “significant legal and evidentiary errors” at the trial.
“We deeply sympathize with anyone suffering from cancer, which is why the facts are so important,” the company said. “We remain confident that our talc is safe, asbestos free, and does not cause cancer.”
COVID-19 reinfection unlikely for at least six months, study finds
“This is really good news, because we can be confident that, at least in the short term, most people who get COVID-19 won’t get it again,” said David Eyre, a professor at Oxford’s Nuffield Department of Population Health, who co-led the study.
At 12 billion, IoT connections to surpass non-IoT devices in 2020
“By 2025, it is expected that there will be more than 30 billion IoT connections, almost 4 IoT devices per person on average,” said Knud Lasse Lueth, Founder and CEO of IoT Analytics.
Will finalise data protection law very soon: Ravi Shankar Prasad
Prasad said major global companies, including from India, have committed to invest close to Rs 11 lakh crore in the next five years and proposed to manufacture mobiles and components, out of which Rs seven lakh crore would be only for exports.
New Microsoft programme to nurture health tech startups in India
“Our partnership with Microsoft for HealthTech startups will focus on enabling these companies to fast track their progress with some of the best technology resources and accelerate their innovation pathways.”.
COVID-19 caseload in India breaches 90-lakh mark
The COVID-19 case fatality rate has further declined to 1.46 per cent.There are 4,43,794 active cases of coronavirus infection in the country which comprises 4.92 per cent of the total caseload, the data stated
According to the ICMR, a cumulative total of 12,95,91,786 samples have been tested up to November 20 with 10,83,397 samples being tested on Thursday